Table 3.
Global Rating Scale | N(*) | Feeling better | N(*) | Feeling same | N(*) | Feeling worse | ||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Mean | 95% CI | Mean | 95% CI | Mean | 95% CI | |||||||
Baseline CIS-R | Initial GAD-7 | |||||||||||
≤11 | 36 | 3.05 | (2.26 | 4.01) | 78 | 1.92 | (1.51 | 2.37) | 9 | 5.24 | (3.07 | 7.88) |
12–19 | 25 | 5.62 | (4.14 | 7.26) | 58 | 6.23 | (5.25 | 7.33) | 9 | 5.24 | (3.02 | 7.82) |
20+ | 32 | 9.02 | (7.37 | 10.93) | 117 | 11.12 | (10.18 | 11.98) | 36 | 13.97 | (12.38 | 15.39) |
Change per 2 weeks | ||||||||||||
≤11 | −0.81 | (−1.18 | −0.50) | −0.27 | (−0.44 | −0.11) | 0.86 | (0.27 | 1.54) | |||
12–19 | −1.50 | (−2.04 | −1.03) | −0.53 | (−0.92 | −0.11) | 0.00 | (−0.47 | 0.50) | |||
20+ | −1.56 | (−1.96 | −1.16) | −0.42 | (−0.76 | −0.08) | 0.67 | (0.28 | 1.06) | |||
Change per 2 weeks as a percentage of baseline GAD7 score | ||||||||||||
≤11 | −0.26 | (−0.34 | −0.19) | −0.14 | (−0.21 | −0.06) | 0.17 | (0.05 | 0.30) | |||
12–19 | −0.27 | (−0.34 | −0.20) | −0.09 | (−0.15 | −0.02) | 0.00 | (−0.09 | 0.10) | |||
20+ | −0.17 | (−0.22 | −0.13) | −0.04 | (−0.07 | −0.01) | 0.05 | (0.02 | 0.08) |
N denotes sample size at baseline for each group. Detailed account of the number of participants contributing to the estimates in each visit is given in Appendix 2 Figure S2.1.